MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

508370

Report Date :

10.05.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

BRAWN LABORATORIES LIMITED

 

 

Registered Office :

4B, Asaf Ali Road, II Floor, Old Delhi Stock Exchange Building, New Delhi – 110002

Tel. No.:

91-11-29815331/ 23275208/ 32911528/ 32911529

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

27.03.1990

 

 

Com. Reg. No.:

55-039653

 

 

Capital Investment / Paid-up Capital :

INR 9.950 Million

 

 

CIN No.:

[Company Identification No.]

U73200DL1990PLC039653

 

 

IEC No.:

[Import-Export Code No.]

Not Divulged

 

 

PAN No.:

[Permanent Account No.]

AAACB7151N

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Divulged

 

 

GSTN :

[Goods & Service Tax Registration No.]

07AAACB7151N1ZI

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

·         Manufacturing and sale of pharmaceutical products

·         The Company operates in business of manufacturing and distribution of drugs. (Registered Activity)

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A+

 

Credit Rating

Explanation

Rating Comments

A+

Low Risk

Business dealings permissible with low risk of default

 

Maximum Credit Limit :

USD 810000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company incorporated in the year 1990 and it is having good track.

 

For the financial year 2017, the company has increased in its revenue from operations as compared to previous year and maintained decent profitability margin of 4.45%.

 

Rating takes into consideration sound financial profile of the company marked by adequate networth base and low debt balance sheet.

 

Further, rating also derives strength from its vast experience of the promoters in the field of pharmaceutical products, established track record of business operations along with market position and improvement in the revenue as well profitability profile during the year.

 

However, ratings strength is partially offset by intense competition due to presence of a large number of generic formulation drug manufacturers.

 

Trade relations are reported as fair. Business is active. Payment terms are seems to be regular.

 

In view of the aforesaid, the company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

ICRA

Rating

Long term rating : BBB-

Rating Explanation

Moderate degree of safety and moderate credit risk

Date

21.08.2017

 

Rating Agency Name

ICRA

Rating

Short term rating : A3

Rating Explanation

Moderate degree of safety and higher credit risk

Date

21.08.2017

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2018.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 10.05.2018

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

INFORMATION DECLINED

 

Management non-cooperative (Tel No.: 91-124-4222462/ 23275208/ 91-11-4666152)

 

LOCATIONS

 

Registered Office/ Export Office :

4B, Asaf Ali Road, II Floor, Old Delhi Stock Exchange Building, New Delhi – 110002, India

Tel. No.:

91-11-29815331/ 23275208/ 32911528/ 32911529

Fax No.:

91-11-23275208

E-Mail :

solution@brawnbiotech.com

export@brawnlabs.com

Website :

http://www.brawnlabs.com

 

 

Corporate Office :

Plot No. 30, Sector 33, Near Hero Motors Factory, Opposite Infocity – II, Gurugram – 122001, Haryana, India

Tel. No.:

91-124-4666152

Fax No.:

91-124-4666152

E-Mail :

international@brawnlabs.com

 

 

Factory 1 :

13, New Industrial Township, Industrial Area, Faridabad-121001, Haryana, India

Tel. No.:

91-129-3290659, 3290738, 4027514

Fax No.:

91-129-4028514

E-Mail :

plant_fbd@brawnlabs.com

 

 

R&D Center :

Plot No. 78, Sector 37, Pace City, Gurugram – 122001, Haryana, India

Tel. No.:

91-124-2370486

 

 

DIRECTORS

 

As on 31.03.2017

 

Name :

Mr. Adarsh Kumar Gupta

Designation :

Director

Address :

GM-38, Phase – II, Gulmohar Marg, DLF, Gurugram – 122008, Haryana, India

Date of Birth/Age :

24.11.1947

Date of Appointment :

23.04.2001

PAN No.:

AFSPG7840M

DIN No.:

00975059

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U74899DL1987PTC028777

A B PHARMA PRIVATE LIMITED

30/06/1988

-

U51397DL2003PTC120157

OVERSEAS LABORATORIES PRIVATE LIMITED

02/05/2003

-

 

 

Name :

Mr. Brij Raj Gupta

Designation :

Director

Address :

GM-38, Phase – II, Gulmohar Marg, DLF, Gurugram – 122008, Haryana, India

Date of Birth/Age :

15.04.1952

Date of Appointment :

23.04.2003

PAN No.:

AESPG6887R

DIN No.:

00974969

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

L74899DL1985PLC022468

BRAWN BIOTECH LIMITED

07/11/1985

-

U74899DL1987PTC028777

A B PHARMA PRIVATE LIMITED

30/06/1988

-

U51397DL2003PTC120157

OVERSEAS LABORATORIES PRIVATE LIMITED

02/05/2003

-

U74999HR2017PTC068281

BRAWN COSMETICS AND HERBALS PRIVATE LIMITED

23/03/2017

-

 

 

Name :

Mr. Love Gupta

Designation :

Director

Address :

GM-38, Phase – II, Gulmohar Marg, DLF, Gurugram – 122008, Haryana, India

Date of Birth/Age :

06.09.1982

Date of Appointment :

05.10.2010

DIN No.:

01385755

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U24290DL2017PTC311474

BRAWN MEDICHEM PRIVATE LIMITED

06/02/2017

-

U74999HR2017PTC068281

BRAWN COSMETICS AND HERBALS PRIVATE LIMITED

12/05/2017

-

 

 

Name :

Mr. Rajveer Singh

Designation :

Director

Address :

B-21, Panchseel Colony, Lal Kuan, Ghaziabad-201009, Uttar Pradesh, India

Date of Birth/Age :

06.03.1970

Date of Appointment :

05.10.2010

PAN No.:

ATAPS3435L

DIN No.:

03464649

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U74999HR2017PTC068281

BRAWN COSMETICS AND HERBALS PRIVATE LIMITED

12/05/2017

-

 

 

Name :

Mr. Nanak Singh Rana

Designation :

Director

Address :

H. No. 854, Sector -10, Gurugram, Haryana, India

Date of Birth/Age :

01.04.1969

Date of Appointment :

30.09.2014

PAN No.:

AGWPR6983M

DIN No.:

07021022

 

 

Name :

Mr. Rakesh Kumar Dhama

Designation :

Director

Address :

A-85 A, GL 5, Hardev Puri, Delhi, India

Date of Birth/Age :

05.01.1964

Date of Appointment :

05.10.2010

PAN No.:

AEYPD6058B

DIN No.:

03520428

 

 

Name :

Mr. Bal Kishan Sharma

Designation :

Director

Address :

212, 213 - Vipin Garden Extension, Delhi-110058, India 

Date of Birth/Age :

05.01.1964

Date of Appointment :

28.03.2015

DIN No.:

02672827

 

MAJOR SHAREHOLDERS

 

As on 31.03.2017

 

Names of Shareholders

 

No. of Shares

A B Pharma Private Limited, India

 

10000

Sree Ram Gupta

 

22260

Atul Gupta

 

75310

Shashi Bala Gupta

 

406410

Brij Bala Gupta

 

21885

Mamta Gupta

 

810

Bhawna Gupta

 

17610

Adarsh Kumar Gupta

 

55000

Brij Raj Gupta

 

278910

Kavita Gupta

 

14300

Nitin Gupta

 

92525

Total

 

995020

 

Equity Share Break up (Percentage of Total Equity)

 

As on 30.09.2017

 

Category

Percentage

Promoters (Individual/Hindu Undivided Family – Indian)

54.70

Public/Other than promoters (Individual/Hindu Undivided Family – Indian)

44.29

Public/Other than promoters (Body corporate)

1.01

Total 

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

·         Manufacturing and Sale of pharmaceutical products

·         The Company operates in business of manufacturing and distribution of drugs. (Registered Activity)

 

 

Products / Services :

Item Code No.

Products/Services Description

99931950

Laboratory Services

 

NIC Code No.

Products/Services Description

24232

Company operates in business of manufacturing and distribution of drugs

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged 

 

 

Imports :

Not Divulged 

 

 

Terms :

Not Divulged 

 

PRODUCTION STATUS – (NOT AVAILABLE)

 

 

GENERAL INFORMATION

 

Suppliers :

 

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

 

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

Not Divulged

 

 

Bankers :

 

Banker Name :

Punjab National Bank

Branch :

BO: Tropical Building, Connaught Place, New Delhi-110002, India

Person Name (With Designation) :

--

Contact Number :

--

Name of Account Holder :

--

Account Number :

--

Account Since (Date/Year of Account Opening) :

--

Average Balance Maintained :

--

Credit Facilities Enjoyed (CC/OD/Term Loan) :

--

Account Operation :

--

Remark :

--

 

 

Facilities :

Secured Loan

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Long-term Borrowings

 

 

Rupee term loans from banks

0.886

0.000

Rupee term loans from others

36.750

0.000

 

 

 

Short-term borrowings

 

 

Working capital loans from banks

128.324

164.685

Total

165.96

164.685

 

Auditors :

 

Name :

Rajiv Udai and Associates

Chartered Accountants

Address :

A-36, 1st Floor, Gurunanak Pura, Laxmi Nagar, Delhi-110092, India

Income-tax PAN of auditor or auditor's firm :

AAGFR7732J

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Enterprises which are owned, or have significant influence of or are partners with Key management personnel and their relatives:

  • Delhi Pharma
  • Brawn Biotech Limited
  • Shashi prints

 

 

Other Related Party:

  • Brawn Herbals

 

 

CAPITAL STRUCTURE

 

As on 30.09.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1000000

Equity Shares

INR 10/- each

INR 10.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

995020

Equity Shares

INR 10/- each

INR 9.950 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

9.950

9.950

9.950

(b) Reserves and Surplus

272.751

189.663

163.221

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

282.701

199.613

173.171

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

49.061

57.425

140.723

(b) Deferred tax liabilities (Net)

0.000

0.000

3.539

(c) Other long-term liabilities

16.740

16.740

17.630

(d) long-term provisions

10.649

4.787

2.512

Total Non-current Liabilities (3)

76.450

78.952

164.404

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

128.324

164.685

350.855

(b) Trade payables

133.724

110.151

102.860

(c) Other current liabilities

166.665

94.819

53.519

(d) Short-term provisions

53.951

13.786

17.829

Total Current Liabilities (4)

482.664

383.441

525.063

 

 

 

 

TOTAL

841.815

662.006

862.638

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

218.929

137.066

135.107

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Tangible assets capital work-in-progress

5.021

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.344

0.749

0.000

(d) Long-term loans and advances

3.431

3.198

3.728

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

227.725

141.013

138.835

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

141.987

172.742

284.893

(c) Trade receivables

400.255

324.044

406.144

(d) Cash and bank balances

19.153

10.066

15.900

(e) Short-term loans and advances

51.588

13.153

16.158

(f) Other current assets

1.107

0.988

0.708

Total Current Assets

614.090

520.993

723.803

 

 

 

 

TOTAL

841.815

662.006

862.638

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Revenue from operations

1866.004

1562.716

1348.945

 

Other Income

20.430

17.609

15.004

 

TOTAL

1886.434

1580.325

1363.949

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

1271.889

1089.961

982.770

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

27.270

60.110

1.474

 

Employee benefit expense

157.137

119.600

93.254

 

Expenditure on production, transportation and

Other expenditure pertaining to exploration

and production activities

73.029

67.732

0.000

 

CSR expenditure

0.000

0.000

0.000

 

Other expenses

189.719

140.300

172.467

 

TOTAL

1719.044

1477.703

1249.965

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

167.390

102.622

113.984

 

 

 

 

 

Less

FINANCIAL EXPENSES

18.122

50.247

66.135

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

149.268

52.375

47.849

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

25.740

20.359

25.549

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

123.528

32.016

22.300

 

 

 

 

 

Less

TAX

40.440

5.574

8.342

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

83.088

26.442

13.958

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

1206.526 

1038.844 

916.078 

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

43.400

29.518

7.926

 

TOTAL IMPORTS

43.400

29.518

7.926

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

83.50

26.57

14.03

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

0.000

0.280

17.130

Net cash flows from (used in) operations

224.712

347.232

89.974

Net cash flows from (used in) operating activities

224.712

347.232

89.974

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

78.29

75.69

109.90

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

4.66

4.82

3.32

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

38.38

36.89

38.20

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

1.18

0.59

0.40

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.75

0.75

0.84

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.63

0.67

0.79

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.63

1.11

2.94

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

1.71

1.92

3.03

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.79

0.69

0.78

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

9.24

2.04

1.72

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin

((PAT / Sales) * 100)

%

4.45

1.69

1.03

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

9.87

3.99

1.62

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

29.39

13.25

8.06

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

1.27

1.36

1.38

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.98

0.91

0.84

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.34

0.30

0.20

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

17.83

22.35

51.13

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.27

1.36

1.38

 

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Share Capital

9.950

9.950

9.950

Reserves & Surplus

163.221

189.663

272.751

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

173.171

199.613

282.701

 

 

 

 

Long-term borrowings

140.723

57.425

49.061

Short term borrowings

350.855

164.685

128.324

Current maturities of long-term debts

17.130

0.280

0.000

Total borrowings

508.708

222.390

177.385

Debt/Equity ratio

2.938

1.114

0.627

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

1348.945

1562.716

1866.004

 

 

15.847

19.408

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

1348.945

1562.716

1866.004

Profit/ (Loss)

13.958

26.442

83.088

 

1.03 %

1.69 %

4.45 %

 

 

 

ABRIDGED BALANCE SHEET (CONSOLIDATED)

 

SOURCES OF FUNDS

 

 

31.03.2017

31.03.2016

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

9.950

9.950

(b) Reserves and Surplus

 

272.745

189.663

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

282.695

199.613

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

49.061

57.425

(b) Deferred tax liabilities (Net)

 

0.000

0.000

(c) Other long-term liabilities

 

16.740

16.740

(d) long-term provisions

 

10.649

4.787

Total Non-current Liabilities (3)

 

76.450

78.952

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

 

128.324

164.685

(b) Trade payables

 

133.724

110.151

(c) Other current liabilities

 

166.677

94.819

(d) Short-term provisions

 

53.951

13.786

Total Current Liabilities (4)

 

482.676

383.441

 

 

 

 

TOTAL

 

842.305

662.006

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

218.929

137.066

(ii) Intangible Assets

 

0.000

0.000

(iii) Tangible assets capital work-in-progress

 

5.021

0.000

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.000

0.000

(c) Deferred tax assets (net)

 

0.344

0.749

(d) Long-term loans and advances

 

3.431

3.198

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

227.725

141.013

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

141.987

172.742

(c) Trade receivables

 

400.255

324.044

(d) Cash and bank balances

 

19.153

10.066

(e) Short-term loans and advances

 

51.588

13.153

(f) Other current assets

 

1.597

0.988

Total Current Assets

 

614.580

520.993

 

 

 

 

TOTAL

 

842.305

662.006

 

 

PROFIT & LOSS ACCOUNT (CONSOLIDATED)

 

 

PARTICULARS

 

31.03.2017

31.03.2016

 

SALES

 

 

 

 

Revenue from operations

 

1866.004

1562.717

 

Other Income

 

20.430

17.609

 

TOTAL

 

1886.434

1580.326

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

 

1271.889

1089.961

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

 

27.270

60.110

 

Employee benefit expense

 

157.137

119.600

 

Expenditure on production, transportation and

Other expenditure pertaining to exploration

and production activities

 

73.031

67.732

 

Other expenses

 

189.719

140.300

 

TOTAL

 

1719.046

1477.703

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

 

167.388

102.623

 

 

 

 

 

Less

FINANCIAL EXPENSES

 

18.122

50.247

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

 

149.266

52.376

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

 

25.740

20.359

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

 

123.526

32.017

 

 

 

 

 

Less

TAX

 

40.440

5.574

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

 

83.086

26.443

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

 

83.50

26.57

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of establishment

Yes

2]

Constitution of the entity Incorporation details

Yes

3]

Locality of the entity

Yes

4]

Premises details

No

5]

Buyer visit details

--

6]

Contact numbers

Yes

7]

Name of the person contacted

No

8]

Designation of contact person

No

9]

Promoter’s background

Yes

10]

Date of Birth of Proprietor / Partners / Directors

Yes

11]

Pan Card No. of Proprietor / Partners

Yes

12]

Voter Id Card No. of Proprietor / Partners

No

13]

Type of business

Yes

14]

Line of Business

Yes

15]

Export/import details (if applicable)

No

16]

No. of employees

No

17]

Details of sister concerns

Yes

18]

Major suppliers

No

19]

Major customers

No

20]

Banking Details

Yes

21]

Banking facility details

Yes

22]

Conduct of the banking account

--

23]

Financials, if provided

Yes

24]

Capital in the business

Yes

25]

Last accounts filed at ROC, if applicable

Yes

26]

Turnover of firm for last three years

Yes

27]

Reasons for variation <> 20%

--

28]

Estimation for coming financial year

No

29]

Profitability for last three years

Yes

30]

Major shareholders, if available

Yes

31]

External Agency Rating, if available

Yes

32]

Litigations that the firm/promoter involved in

--

33]

Market information

--

34]

Payments terms

No

35]

Negative Reporting by Auditors in the Annual Report

No

 

NOTE: Registered office of the company has been shifted from C-64, Lajpat Nagar, New Delhi – 110024, India to the present address w.e.f. 31.05.2017

 

 

GENERAL INFORMATION

 

The company was established in the year 1990. The company manufactures a wide variety of finished formulations from a large number of therapeutic segments to include Antibiotics – Antibacterials, Cardiovascular, Antidiabetics, Anxiolytics and Antidepressants, Gastrointestinals, Cough and Cold, Analgesics – Anti-inflammatories, Anti Tubercular, Antihelminthics, Antifungals, Anti protozoals, Antivirals, Antimalarials, Antihistaminics, Corticosteroids, Nutritional supplements and others.

 

 

PERFORMANCE:

 

The turnover and other income of your company for the current year stood at INR 1886.434 Million as compared to INR 1580.325 Million for the previous year.

 

 

UNSECURED LOAN

 

PARTICULAR

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Long-term Borrowings

 

 

Deposits from others

4.650

4.050

Loans and advances from related parties

6.775

52.775

Other loans and advances

0.000

0.600

Total

11.425

57.425

 

 

INDEX OF CHARGES

 

S

No

SRN

Charge Id

Charge Holder Name

Date of Creation

Date of Modification

Date of Satisfaction

Amount

Address

1

C05993068

10501705

PUNJAB NATIONAL BANK

27/02/2014

-

-

732284.0

BO: TROPICAL BUILDING CONNAUGHT PLACE NEW DELHI 110002 INDIA

2

B97692743

10480812

Punjab National Bank

18/01/2014

-

-

441248.0

TROPICAL BUILDING CONNAUGHT PLACE NEW DELHI-110001 INDIA

3

B85985026

10451628

Punjab National Bank

06/09/2013

-

-

10000000.0

H-22, TROPICAL BUILDING,CONNAUGHT PLACE NEW DELHI- 110001 INDIA

4

B13344890

10287992

PUNJAB NATIONAL BANK

24/05/2011

-

-

425000.0

TROPICAL BUILDING CONNAUGHT PLACE NEW DELHI-110001 INDIA

5

G39910385

10123280

PUNJAB NATIONAL BANK

13/09/2008

07/03/2017

-

390000000.0

BO: TROPICAL BUILDING CONNAUGHT PLACE NEW DELHI 110002 INDIA

6

B26083279

10269840

PUNJAB NATIONAL BANK

04/02/2011

-

30/11/2011

40000000.0

TROPICAL BUILDING CONNAUGHT PLACE NEW DELHI-110001 INDIA

7

B26082008

10269831

PUNJAB NATIONAL BANK

14/02/2011

-

30/11/2011

10000000.0

TROPICAL BUILDING CONNAUGHT PLACE NEW DELHI-110001 INDIA

8

B26091777

10176661

PUNJAB NATIONAL BANK

09/09/2009

-

30/11/2011

10000000.0

TROPICAL BUILDING CONNAUGHT PLACE NEW DELHI-110001 INDIA

9

B26098426

10148858

PUNJAB NATIONAL BANK

06/03/2009

-

30/11/2011

10000000.0

TROPICAL BUILDING CONNAUGHT PLACE NEW DELHI-110001 INDIA

10

B26099192

10148861

PUNJAB NATIONAL BANK

03/03/2009

-

30/11/2011

10000000.0

TROPICAL BUILDING CONNAUGHT PLACE NEW DELHI-110001 INDIA

 

 

FIXED ASSETS

 

  • Land
  • Building
  • Plant and equipment
  • Vehicles
  • Furniture and Fixture

 

 

 

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 67.38

UK Pound

1

INR 91.09

Euro

1

INR 79.75

 

 

INFORMATION DETAILS

 

Information Gathered by :

ARC

 

 

Analysis Done by :

PSD

 

 

Report Prepared by :

JYTK / RKI

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.